These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20929928)

  • 1. Mitochondrially localized EGFR is independent of its endocytosis and associates with cell viability.
    Yao Y; Wang G; Li Z; Yan B; Guo Y; Jiang X; Xi Z
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):763-70. PubMed ID: 20929928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrially localized EGFR is subjected to autophagic regulation and implicated in cell survival.
    Yue X; Song W; Zhang W; Chen L; Xi Z; Xin Z; Jiang X
    Autophagy; 2008 Jul; 4(5):641-9. PubMed ID: 18398293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
    Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
    Wang Q; Zhu F; Wang Z
    Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
    Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression.
    Jiang J; Greulich H; Jänne PA; Sellers WR; Meyerson M; Griffin JD
    Cancer Res; 2005 Oct; 65(19):8968-74. PubMed ID: 16204070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax activation and translocation to mitochondria mediate EGF-induced programmed cell death.
    Tikhomirov O; Carpenter G
    J Cell Sci; 2005 Dec; 118(Pt 24):5681-90. PubMed ID: 16303853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the anti-cancer peptide EGFR-lytic hybrid peptide in human pancreatic cancer BxPC-3 cells by immunocytochemistry.
    Ohara K; Kohno M; Kawakami K
    J Pept Sci; 2013 Aug; 19(8):511-5. PubMed ID: 23813780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway.
    Lu PH; Kuo TC; Chang KC; Chang CH; Chu CY
    Br J Dermatol; 2011 Jan; 164(1):38-46. PubMed ID: 20846305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.
    Munk M; Memon AA; Nexo E; Sorensen BS
    BJU Int; 2007 Jan; 99(1):196-201. PubMed ID: 17092291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.
    Höpfner M; Sutter AP; Huether A; Schuppan D; Zeitz M; Scherübl H
    J Hepatol; 2004 Dec; 41(6):1008-16. PubMed ID: 15582135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.
    Kobayashi S; Ji H; Yuza Y; Meyerson M; Wong KK; Tenen DG; Halmos B
    Cancer Res; 2005 Aug; 65(16):7096-101. PubMed ID: 16103058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.
    Van Schaeybroeck S; Karaiskou-McCaul A; Kelly D; Longley D; Galligan L; Van Cutsem E; Johnston P
    Clin Cancer Res; 2005 Oct; 11(20):7480-9. PubMed ID: 16243822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
    Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells.
    Ariyama H; Qin B; Baba E; Tanaka R; Mitsugi K; Harada M; Nakano S
    J Cell Biochem; 2006 Mar; 97(4):724-34. PubMed ID: 16229013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis.
    Johannessen LE; Ringerike T; Molnes J; Madshus IH
    Exp Cell Res; 2000 Oct; 260(1):136-45. PubMed ID: 11010818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.
    Wiedmann M; Feisthammel J; Blüthner T; Tannapfel A; Kamenz T; Kluge A; Mössner J; Caca K
    Anticancer Drugs; 2006 Aug; 17(7):783-95. PubMed ID: 16926628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
    Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
    Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
    Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.